Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.0002
Schlusskurs vom Vortag:
$0.0002
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$N/A
Einnahmen:
$7.68M
Nettoeinkommen (Verlust:
$-42.95M
KGV:
0.00
EPS:
-6.4055
Netto-Cashflow:
$-36.62M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.0007
52-Wochen-Spanne:
$0.00
$0.0222
T 2 Biosystems Inc Stock (TTOO) Company Profile
Firmenname
T 2 Biosystems Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare TTOO vs TMO, DHR, IDXX, A, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TTOO
T 2 Biosystems Inc
|
0.00 | 0 | 7.68M | -42.95M | -36.62M | -6.4055 |
TMO
Thermo Fisher Scientific Inc
|
568.26 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
191.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
544.32 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
138.57 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.99 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-27 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2019-11-26 | Herabstufung | Janney | Buy → Neutral |
| 2019-08-01 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2019-07-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-07-31 | Herabstufung | Janney | Buy → Neutral |
| 2019-05-16 | Eingeleitet | Alliance Global Partners | Buy |
| 2019-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-06-01 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-05-30 | Bestätigt | H.C. Wainwright | Buy |
| 2018-05-29 | Bestätigt | WBB Securities | Strong Buy |
| 2018-03-29 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-29 | Eingeleitet | Goldman | Neutral |
| 2017-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-03-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Mkt Perform |
| 2016-11-02 | Bestätigt | Cantor Fitzgerald | Buy |
| 2016-07-20 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2016-06-22 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2016-04-12 | Bestätigt | Canaccord Genuity | Buy |
| 2016-02-17 | Eingeleitet | WBB Securities | Speculative Buy |
Alle ansehen
T 2 Biosystems Inc Aktie (TTOO) Neueste Nachrichten
Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026 - Yahoo! Finance Canada
TTOO Price History for T2 Biosystems CS Stock - Barchart.com
Lyme Disease Testing Market Analysis Highlights Growth To $16.46 Billion By 2030 At 9% CAGR - openPR.com
Imagion Biosystems, Siemens Healthineers Extend Imaging Agent Collaboration - Imaging Technology News
Price to sales forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
Price to earnings forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
Enterprise value to revenue forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
Price to book forward of T2 Biosystems, Inc. – OTC:TTOO - TradingView
T2 Biosystems, Inc. Actuals & Estimates (OTC:TTOO) - TradingView
T2 Biosystems, Inc. Actuals & Estimates (LSE:0A57) - TradingView
Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial - Business Wire
Lyme Disease Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Abbott, Bio-Rad Labs, Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems - Barchart.com
BioSystems Engineering (01355) plans to conduct a rights issue on a "2-for-1" basis, aiming to raise up to approximately HK$39 million in net proceeds. - Moomoo
Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD - BioSpace
Rapid Carbapenem-Resistant Organism Identification Market Growth to Accelerate by 2035 Driven by Multiplex Syndromic PanelsNews and Statistics - IndexBox
Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review - Medianet News Hub
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering - Yahoo Finance
T2 Biosystems Inc (OTCM:TTOO) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
T2 Biosystems Inc (OTCM:TTOO) Stock Earnings Transcripts - GuruFocus
T2 Biosystems Inc (OTCM:TTOO) Stock Price & 30 Year Financial Data - GuruFocus
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Number of shareholders of T2 Biosystems, Inc. – OTC:TTOO - TradingView
Leica Biosystems unveils next-generation digital pathology scanner and AI-powered QC software - Drug Discovery News
Financial Analysis: Biostage (OTCMKTS:BSTG) and T2 Biosystems (NASDAQ:TTOO) - defenseworld.net
T2 Biosystems (NASDAQ:TTOO) Stock Passes Below 200-Day Moving Average – Time to Sell? - Defense World
Aspect Biosystems secures $79-million in federal funding to advance 3-D tissue printing technology - The Globe and Mail
TTOO (T2 Biosystems) PB Ratio : (As of Mar. 27, 2026) - GuruFocus
TTOO stock $0.0001 on NASDAQ 19 Mar 2026 Market Closed: top losers risk - Meyka
T2 Biosystems2026 Funding Rounds & List of Investors - Tracxn
T2 Biosystems, Inc. Announces Intent to Complete Winding Down of Operations - marketscreener.com
TTOO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
New hires at Rapid Micro Biosystems get 205K RSUs, 168K options - Stock Titan
Critical Review: Acutus Medical (NASDAQ:AFIB) & T2 Biosystems (NASDAQ:TTOO) - Defense World
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent - BioSpace
T2 Biosystems announces intent to wind down operations - marketscreener.com
Targeted Imaging Agent Submitted to FDA for IND Application - Imaging Technology News
TTOO Stock Price and Chart — OTC:TTOO - TradingView
T2 Biosystems announces plans to license technology to expand its leadership - Intellectia AI
T2 Biosystems (NASDAQ:TTOO) Shares Cross Below Two Hundred Day Moving Average – Should You Sell? - Defense World
Lyme Disease Diagnostic Devices Market Valuation Expected - openPR.com
Aspect Biosystems expands partnership with Novo Nordisk to develop diabetes treatment - The Globe and Mail
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - simplywall.st
T2 Biosystems (NASDAQ:TTOO) versus Minerva Surgical (NASDAQ:UTRS) Head-To-Head Review - Defense World
T2 Biosystems (TTOO) Earnings Calendar_Earnings Analysis_Financial Report and Earnings Call - Tiger Brokers
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) last week's 10% decline must have disappointed private equity firms who have a significant stake - simplywall.st
Ocean Dx sepsis test matches gold standard in early study - BioWorld News
DHAI Stock Price and Chart — OTC:DHAI - TradingView
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - Yahoo Finance
NAVBQ Stock Price and Chart — OTC:NAVBQ - TradingView
Imagion Biosystems (ASX:IBX) gets ready for Phase 2 - Stocks Down Under
Finanzdaten der T 2 Biosystems Inc-Aktie (TTOO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.02%
0.35%
Kapitalisierung:
|
Volumen (24h):